Searchable abstracts of presentations at key conferences in endocrinology

ea0059p128 | Neuroendocrinology and pituitary | SFEBES2018

Are silent corticotroph adenomas high risk tumours for recurrence? Systematic review and meta-analysis

Fountas Athanasios , Lavrentaki Aikaterini , Subramanian Anuradhaa , Toulis Konstantinos , Nirantharakumar Krishnarajah , Karavitaki Niki

Introduction: The 2017 WHO Classification of Pituitary Tumors grades silent corticotroph adenomas (SCAs) as high-risk adenomas due to their aggressive clinical behaviour (high probability of recurrence). Nonetheless, studies comparing recurrence rates of SCA with other non-functioning pituitary adenomas (NFPAs) subtypes have provided conflicting results necessitating review of the evidence this recommendation relies on.Aims: To estimate recurrence rates ...

ea0092op-11-04 | Oral Session 11: Autoimmunity / Hyperthyroidism | ETA2023

Comparison of long-term mortality and cardiometabolic effects of treatment for hyperthyroidism: egret study

Torlinska Barbara , Hazlehurst Jonathan , Nirantharakumar Krishnarajah , Neil Thomas G. , Abrams Keith , Boelaert Kristien

Objectives: Hyperthyroidism has been linked to long-term cardiovascular and metabolic morbidity and increased mortality. Current evidence indicates differential cardio-metabolic effects from antithyroid drugs (ATD) and definitive treatment options (radioiodine or thyroidectomy). We aimed to assess differences in mortality and cardiometabolic outcomes depending on treatment modality to better inform patient-clinician decision-making.Methods: We identified...

ea0086op1.2 | Thyroid | SFEBES2022

Long-term mortality and cardiometabolic effects of treatment for hyperthyroidism: EGRET study

Torlinska Barbara , Hazlehurst Jonathan M. , Nirantharakumar Krishnarajah , Neil Thomas G. , Priestley Julia , Abrams Keith R. , Boelaert Kristien

Hyperthyroidism has been linked to long-term cardiovascular and metabolic morbidity and increased mortality. We aimed to assess differences in mortality and cardiometabolic outcomes depending on treatment modality to better inform patient-clinician decision-making.Methods: We identified 62,474 patients with newly diagnosed hyperthyroidism, treated with antithyroid drugs (ATD), radioiodine or thyroidectomy from a UK population-based GP database (>16M ...

ea0063gp188 | Adrenal and Neuroendocrine - Clinical | ECE2019

Increased risk of infections in Addison’s disease and congenital adrenal hyperplasia patients: a longitudinal study based on a United Kingdom primary care database

Tresoldi Alberto S , Sumilo Dana , Perrins Mary , Toulis Konstantinos A , Prete Alessandro , Reddy Narendra , Wass John A , Nirantharakumar Krishnarajah , Arlt Wiebke

Background: Primary adrenal insufficiency (PAI) can be of autoimmune origin (Addison’s disease, AD) or due to inborn disorders of steroidogenesis (congenital adrenal hyperplasia, CAH). Prognosis of patients with PAI has improved considerably after glucocorticoid replacement therapy became available. However, even in recent years, an increased risk of death has been described in both AD and CAH patients. Moreover, even with the current state-of-the-art replacement therapy,...

ea0056gp92 | Diabetes Epidemiology | ECE2018

Gestational Diabetes Mellitus is associated with increased risk of Non-Alcoholic Fatty Liver Disease: A population-based cohort study

Lavrentaki Aikaterini , Subramanian Anuradhaa , Thomas G Neil , Valsamakis George , Toulis Konstantinos , Daly Barbara , Mastorakos George , Tahrani Abd , Nirantharakumar Krishnarajah

Background: Gestational diabetes mellitus (GDM) is associated with adverse perinatal outcomes, and increased risk of post-natal type 2 diabetes and cardiovascular disease. However, whether GDM increases the risk of developing incident Non-alcoholic Fatty Liver Disease (NAFLD) is unclear and has not been well examined in previous studies. This is important considering the significant health burden of NAFLD and the opportunity to interfere in high risk population in order to red...

ea0073pep11.6 | Presented ePosters 11: Adrenal and Cardiovascular Endocrinology | ECE2021

Increased risk of cardiometabolic disease in patients with benign adrenal tumours with and without cortisol excess: a case–control study

Prete Alessandro , Subramanian Anuradhaa , Bancos Irina , Sitch Alice J , Chortis Vasileios , Lang Katharina , Tsagarakis Stylianos , Macech Magdalena , Delivanis Danae A , O’Reilly Michael W , Masjkur Jimmy R , Quinkler Marcus , Ueland Grethe Å , Dennedy M Conall , Beuschlein Felix , Tabarin Antoine , Fassnacht Martin , Ivovic Miomira , Terzolo Massimo , Kastelan Darko , Young William F Jr , Manolopoulos Konstantinos N , Ambroziak Urszula , Vassiliadi Dimitra A , Nirantharakumar Krishnarajah , Arlt Wiebke

BackgroundBenign adrenocortical tumours are found in 3–5% of adults and can be non-functioning (NFAT) or associated with cortisol excess. The latter group divides into patients with clinically overt signs (adrenal Cushing’s syndrome, CS) and patients lacking CS signs (mild autonomous cortisol excess, MACE). The 1 mg-overnight dexamethasone suppression test (DST) further differentiates MACE into MACE-1 (possible MACE; post-DST cortisol 50–1...

ea0077ec1.2 | Early Career Prize Lecture Basic Science (1) | SFEBES2021

Cardiometabolic disease burden and urine steroid metabolome in benign adrenocortical tumours: a case-control study

Prete Alessandro , Subramanian Anuradhaa , Bancos Irina , Chortis Vasileios , Tsagarakis Stylianos , Lang Katharina , Macech Magdalena , Delivanis Danae A , Pupovac Ivana D , Reimondo Giuseppe , Marina Ljiljana V , Deutschbein Timo , Balomenaki Maria , O’Reilly Michael W , Bednarczuk Tomasz , Zhang Catherine , Dusek Tina , Diamantopoulos Aristidis , Asia Miriam , Kondracka Agnieszka , Li Dingfeng , Masjkur Jimmy R , Quinkler Marcus , Ueland Grethe AE , Dennedy M Conall , Beuschlein Felix , Tabarin Antoine , Fassnacht Martin , Ivovic Miomira , Terzolo Massimo , Kastelan Darko , Young Jr William F , Manolopoulos Konstantinos N , Ambroziak Urszula , Vassiliadi Dimitra A , Taylor Angela E , Sitch Alice J , Nirantharakumar Krishnarajah , Arlt Wiebke

Background: The overwhelming majority of incidentally discovered adrenal tumours are benign adrenocortical adenomas. These can be non-functioning (NFAT) or associated with cortisol excess on a spectrum ranging from rare clinically overt adrenal Cushing’s syndrome (CS) to much more prevalent mild autonomous cortisol secretion (MACS) without signs of CS. The 1mg-overnight dexamethasone suppression test (DST) further differentiates MACS-1 (possible MACS; post-DST cortisol 50...